{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T17:26:01.425080+00:00","company":{"ticker":"CORZ","cik":1839341,"company_name":"Core Scientific, Inc./tx"},"pagination":{"limit":100,"returned":98,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"B. Riley Commercial Capital, LLC","detail":"credit_facility","count":2,"first_seen":"2023-02-07T23:59:59+00:00","last_seen":"2023-03-02T23:59:59+00:00","evidence_fact_ids":[174543,181328]},{"display_name":"Two Seas Capital LP","detail":"other","count":2,"first_seen":"2026-02-18T23:59:59+00:00","last_seen":"2026-02-19T23:59:59+00:00","evidence_fact_ids":[31784,31988]},{"display_name":"B. Riley Commercial Capital, LLC, as administrative agent, and the Replacement DIP Lenders","detail":"credit_facility","count":1,"first_seen":"2023-07-06T23:59:59+00:00","last_seen":"2023-07-06T23:59:59+00:00","evidence_fact_ids":[133448]},{"display_name":"Celsius Mining LLC","detail":"asset_purchase","count":1,"first_seen":"2023-09-20T23:59:59+00:00","last_seen":"2023-09-20T23:59:59+00:00","evidence_fact_ids":[112518]},{"display_name":"Consenting Creditors","detail":"other","count":1,"first_seen":"2023-02-13T23:59:59+00:00","last_seen":"2023-02-13T23:59:59+00:00","evidence_fact_ids":[179977]},{"display_name":"Holders of Allowed Miner Equipment Lender Secured Claims that are Settling Miner Equipment Lenders electing Election 2","detail":"credit_facility","count":1,"first_seen":"2024-01-23T23:59:59+00:00","last_seen":"2024-01-23T23:59:59+00:00","evidence_fact_ids":[80276]},{"display_name":"Morgan Stanley Senior Funding, Inc.","detail":"credit_facility","count":1,"first_seen":"2026-03-06T23:59:59+00:00","last_seen":"2026-03-06T23:59:59+00:00","evidence_fact_ids":[29791]},{"display_name":"Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A.","detail":"credit_facility","count":1,"first_seen":"2026-03-23T23:59:59+00:00","last_seen":"2026-03-23T23:59:59+00:00","evidence_fact_ids":[27635]},{"display_name":"Polar Merger Sub, LLC, Polaris DS LLC, Top Access Enterprises Limited, Altair LLC","detail":"merger","count":1,"first_seen":"2026-05-06T23:59:59+00:00","last_seen":"2026-05-06T23:59:59+00:00","evidence_fact_ids":[21361]},{"display_name":"Wilmington Savings Fund Society, FSB","detail":"notes_offering","count":1,"first_seen":"2026-05-06T23:59:59+00:00","last_seen":"2026-05-06T23:59:59+00:00","evidence_fact_ids":[21362]},{"display_name":"Wilmington Savings Fund Society, FSB, as administrative agent, and the lenders from time to time party thereto","detail":"credit_facility","count":1,"first_seen":"2022-12-27T23:59:59+00:00","last_seen":"2022-12-27T23:59:59+00:00","evidence_fact_ids":[189033]},{"display_name":"Wilmington Trust, National Association, as administrative agent and collateral agent, and the lenders party thereto","detail":"credit_facility","count":1,"first_seen":"2024-01-25T23:59:59+00:00","last_seen":"2024-01-25T23:59:59+00:00","evidence_fact_ids":[79658]},{"display_name":"certain holders of Convertible Notes and/or DIP Commitments or loans under the DIP Facility","detail":"notes_offering","count":1,"first_seen":"2022-12-27T23:59:59+00:00","last_seen":"2022-12-27T23:59:59+00:00","evidence_fact_ids":[189034]},{"display_name":"each Holder of an Allowed Miner Equipment Lender Secured Claim that is a Settling Miner Equipment Lender that elected on its Ballot to receive and is receiving the Miner Equipment Lender Treatment Election 2","detail":"credit_facility","count":1,"first_seen":"2024-01-25T23:59:59+00:00","last_seen":"2024-01-25T23:59:59+00:00","evidence_fact_ids":[79659]},{"display_name":"guarantors party thereto and Wilmington Trust, National Association","detail":"notes_offering","count":1,"first_seen":"2024-01-23T23:59:59+00:00","last_seen":"2024-01-23T23:59:59+00:00","evidence_fact_ids":[80277]},{"display_name":"lenders party thereto and Wilmington Trust, National Association","detail":"credit_facility","count":1,"first_seen":"2024-01-23T23:59:59+00:00","last_seen":"2024-01-23T23:59:59+00:00","evidence_fact_ids":[80275]}],"lender":[{"display_name":"U.S. Bank National Association","detail":"convertible_notes","count":2,"first_seen":"2022-12-21T23:59:59+00:00","last_seen":"2022-12-21T23:59:59+00:00","evidence_fact_ids":[189799,189800]},{"display_name":"B. Riley Commercial Capital, LLC","detail":"credit_facility","count":1,"first_seen":"2023-03-02T23:59:59+00:00","last_seen":"2023-03-02T23:59:59+00:00","evidence_fact_ids":[174544]},{"display_name":"BRF Finance Co, LLC and B. Riley Commercial Capital, LLC","detail":"loan","count":1,"first_seen":"2022-12-21T23:59:59+00:00","last_seen":"2022-12-21T23:59:59+00:00","evidence_fact_ids":[189803]},{"display_name":"Barings Private Credit Corp., Barings Capital Investment Corporation and Barings BDC, Inc.","detail":"loan","count":1,"first_seen":"2022-12-21T23:59:59+00:00","last_seen":"2022-12-21T23:59:59+00:00","evidence_fact_ids":[189801]},{"display_name":"BlockFi Lending LLC","detail":"loan","count":1,"first_seen":"2022-12-21T23:59:59+00:00","last_seen":"2022-12-21T23:59:59+00:00","evidence_fact_ids":[189802]},{"display_name":"JPMorgan Chase Bank, N.A.","detail":"credit_facility","count":1,"first_seen":"2026-03-23T23:59:59+00:00","last_seen":"2026-03-23T23:59:59+00:00","evidence_fact_ids":[31526]},{"display_name":"Morgan Stanley Senior Funding, Inc.","detail":"term_loan","count":1,"first_seen":"2026-03-06T23:59:59+00:00","last_seen":"2026-03-06T23:59:59+00:00","evidence_fact_ids":[32586]},{"display_name":"Wilmington Savings Fund Society, FSB","detail":"senior_notes","count":1,"first_seen":"2026-05-06T23:59:59+00:00","last_seen":"2026-05-06T23:59:59+00:00","evidence_fact_ids":[28589]},{"display_name":"Wilmington Savings Fund Society, FSB, as administrative agent, and the DIP Lenders","detail":"credit_facility","count":1,"first_seen":"2022-12-27T23:59:59+00:00","last_seen":"2022-12-27T23:59:59+00:00","evidence_fact_ids":[189036]}]},"facts":[{"fact_type":"executive_change","fact_key":"3443fe67a9","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-26T20:02:20+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-26","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Steve M. Smith was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"On May 26, 2026, the Company announced the appointment of Steve M. Smith, as a member of the Board and the Nominating and Corporate Governance Committee of the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001839341-26-000005","anchor_url":"https://secwatch.observer/filing/0001839341-26-000005#claim-3443fe67a9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000005/0001839341-26-000005-index.htm"},{"fact_type":"shareholder_vote","fact_key":"5d3ff8e08def037b43c7c64def27ee128dcb84b4","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-15T20:05:07+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-12","outcome":"passed","proposal_text":"Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"1,752,370","votes_against":"313,161","votes_for":"262,833,296","votes_withheld":null}]},"claim":"Core Scientific, Inc./tx shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-12 meeting.","evidence_excerpt":"Proposal 3: To ratify the appointment of KPMG LLP","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001839341-26-000002","anchor_url":"https://secwatch.observer/filing/0001839341-26-000002#claim-5d3ff8e08def037b43c7c64def27ee128dcb84b4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000002/0001839341-26-000002-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9877ef8b656270cf8295d028ffd2253d02586e0e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-15T20:05:07+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-12","outcome":"passed","proposal_text":"Advisory approval of named executive officer compensation as disclosed in the 2026 Proxy Statement","proposal_type":"say_on_pay","results":[{"broker_non_votes":"44,778,216","subject":null,"votes_abstain":"2,168,439","votes_against":"79,166,695","votes_for":"138,785,477","votes_withheld":null}]},"claim":"Core Scientific, Inc./tx shareholders approved Advisory approval of named executive officer compensation as disclosed in the 2026 Proxy Statement at the 2026-05-12 meeting.","evidence_excerpt":"Proposal 2: To approve on a non-binding, advisory basis, the compensation of our named executive officers","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001839341-26-000002","anchor_url":"https://secwatch.observer/filing/0001839341-26-000002#claim-9877ef8b656270cf8295d028ffd2253d02586e0e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000002/0001839341-26-000002-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a8f937a1c8b4f56aaf4e5cb5f2e338985f153e61","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-15T20:05:07+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-12","outcome":"passed","proposal_text":"Election of five nominees to the Board of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"44,778,216","subject":"Adam Sullivan","votes_abstain":null,"votes_against":null,"votes_for":"217,650,785","votes_withheld":"2,469,826"},{"broker_non_votes":"44,778,216","subject":"Jeff Booth","votes_abstain":null,"votes_against":null,"votes_for":"168,580,185","votes_withheld":"51,540,426"},{"broker_non_votes":"44,778,216","subject":"Elizabeth Crain","votes_abstain":null,"votes_against":null,"votes_for":"215,074,279","votes_withheld":"5,046,332"},{"broker_non_votes":"44,778,216","subject":"Yadin Rozov","votes_abstain":null,"votes_against":null,"votes_for":"213,054,408","votes_withheld":"7,066,203"},{"broker_non_votes":"44,778,216","subject":"Eric Weiss","votes_abstain":null,"votes_against":null,"votes_for":"168,947,230","votes_withheld":"51,173,381"}]},"claim":"Core Scientific, Inc./tx shareholders approved Election of five nominees to the Board of Directors at the 2026-05-12 meeting.","evidence_excerpt":"Nominee For Withheld Broker Non-Votes Adam Sullivan 217,650,785 2,469,826 44,778,216 Jeff Booth 168,580,185 51,540,426 44,778,216 Elizabeth Crain 215,074,279 5,046,332 44,778,216 Yadin Rozov 213,054,408 7,066,203 44,778,216 Eric Weiss 168,947,230 51,173,381 44,778,216","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001839341-26-000002","anchor_url":"https://secwatch.observer/filing/0001839341-26-000002#claim-a8f937a1c8b4f56aaf4e5cb5f2e338985f153e61","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000183934126000002/0001839341-26-000002-index.htm"},{"fact_type":"debt_financing","fact_key":"3ac3560e9efe29a466b3e359c1a606189530796a","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-06T23:59:59+00:00","payload":{"counterparty":"Wilmington Savings Fund Society, FSB","effective_date":"2026-05-06","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"7.750%","item_codes_triggered":["2.03"],"maturity_text":"May 15, 2031","principal_text":"$3.3 billion"},"claim":"Core Scientific, Inc./tx incurred senior notes of $3.3 billion with Wilmington Savings Fund Society, FSB at 7.750% maturing May 15, 2031.","evidence_excerpt":"On May 6, 2026, Core Scientific Finance I LLC (the “Issuer”), a wholly-owned indirect subsidiary of Core Scientific, Inc. (“Core Scientific”), completed its previously announced private offering (the “Offering”) of $3.3 billion aggregate principal amount of its 7.750% Senior Secured Notes due 2031 (the “Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-208905","anchor_url":"https://secwatch.observer/filing/0001193125-26-208905#claim-3ac3560e9efe29a466b3e359c1a606189530796a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312526208905/0001193125-26-208905-index.htm"},{"fact_type":"earnings_release","fact_key":"48df42c786294b98c9a35dd178960f686a6bbc81","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-06T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$347.2 million","period_text":"first quarter of 2026","report_date":"2026-05-06","result_type":"reported_results","revenue_text":"$115.2 million"},"claim":"Core Scientific, Inc./tx reported first quarter of 2026 results: revenue $115.2 million, net income $347.2 million.","evidence_excerpt":"is accelerating customer discussions and reinforcing the value of our high-density compute infrastructure platform.” First Quarter 2026 Financial Results • Total revenue was $115.2 million compared to $79.5 million in the first quarter of 2025. ◦ Colocation revenue was $77.5 million, up from $8.6 million in the first quarter of 2025, driven by incremental billable","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-031246","anchor_url":"https://secwatch.observer/filing/0001628280-26-031246#claim-48df42c786294b98c9a35dd178960f686a6bbc81","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026031246/0001628280-26-031246-index.htm"},{"fact_type":"material_agreement","fact_key":"5effb6fe300013d5eb450c9b288488697c81096e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Indenture","agreement_type":"notes_offering","counterparty":"Wilmington Savings Fund Society, FSB","effective_date":"2026-05-06","item_codes_triggered":["1.01"],"value_text":"$3.3 billion"},"claim":"Core Scientific, Inc./tx entered into Indenture with Wilmington Savings Fund Society, FSB valued at $3.3 billion (effective 2026-05-06).","evidence_excerpt":"the Notes were issued pursuant to, and are governed by, an indenture (the “Indenture”), dated as of May 6, 2026, between the Issuer, Holdco (as defined below), the Subsidiary Guarantors and Wilmington Savings Fund Society, FSB, as trustee (the “Trustee”) and collateral agent (the “Collateral Agent”)","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-26-208905","anchor_url":"https://secwatch.observer/filing/0001193125-26-208905#claim-5effb6fe300013d5eb450c9b288488697c81096e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312526208905/0001193125-26-208905-index.htm"},{"fact_type":"material_agreement","fact_key":"3311de0b43ca495ced969a604b720b9730151778","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Merger Agreement","agreement_type":"merger","counterparty":"Polar Merger Sub, LLC, Polaris DS LLC, Top Access Enterprises Limited, Altair LLC","effective_date":"2026-05-05","item_codes_triggered":["1.01"],"value_text":"approximately $421 million in cash"},"claim":"Core Scientific, Inc./tx entered into Merger Agreement with Polar Merger Sub, LLC, Polaris DS LLC, Top Access Enterprises Limited, Altair LLC valued at approximately $421 million in cash (effective 2026-05-05).","evidence_excerpt":"On May 5, 2026, Core Scientific, Inc., a Delaware corporation (the “Company”), entered into an agreement and plan of merger (the “Merger Agreement”) with Polar Merger Sub, LLC, a Nevada limited liability company and wholly owned subsidiary of the Company (“Merger Sub”), Polaris DS LLC, a Nevada limited liability company (the “Target”), Top Access Enterprises Limited, a company organized under the laws of Hong Kong and sole owner of the Target (“Seller”), and solely for the purposes of Article XI (and Article I and Article VII to the extent relating thereto) of the Merger Agreement, Altair LLC, an Oklahoma limited liability company (“Parent Sub”), pursuant to which at the effective time of the statutory merger contemplated thereby, Merger Sub will merge with and into the Target (the “Acquisition”), with the Target surviving as a wholly owned subsidiary of the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-030918","anchor_url":"https://secwatch.observer/filing/0001628280-26-030918#claim-3311de0b43ca495ced969a604b720b9730151778","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026030918/0001628280-26-030918-index.htm"},{"fact_type":"executive_change","fact_key":"7dfd04a00b","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-05-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-07","interim":false,"role":"Principal Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jorge Ray was appointed as Principal Accounting Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On April 30, 2026, the Board of Directors of Core Scientific, Inc. (the “Company”) appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-030553","anchor_url":"https://secwatch.observer/filing/0001628280-26-030553#claim-7dfd04a00b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026030553/0001628280-26-030553-index.htm"},{"fact_type":"debt_financing","fact_key":"b2aa4cb119954c07db270113fa76ebc7fc82aa33","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-23T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A.","effective_date":"2026-03-18","event":"incurrence","instrument_type":"credit_facility","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"$500.0 million incremental commitment"},"claim":"Core Scientific, Inc./tx incurred credit facility of $500.0 million incremental commitment with JPMorgan Chase Bank, N.A..","evidence_excerpt":"On March 18, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement (the “Incremental Amendment”), by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A. (“JPM”), as amendment no. 1 term lender, which amends the Company’s existing credit agreement (the “Initial Credit Agreement”) with the lenders party thereto from time to time and the Agent to increase the term loan commitments thereunder by $500.0 million, to $1.0 billion total, pursuant to the accordion feature of the Initial Credit Agreement. The Company borrowed the full $500.0 incremental commitment on the Closing Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-020327","anchor_url":"https://secwatch.observer/filing/0001628280-26-020327#claim-b2aa4cb119954c07db270113fa76ebc7fc82aa33","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026020327/0001628280-26-020327-index.htm"},{"fact_type":"material_agreement","fact_key":"d14b898b564449fae95773dafaddcef14e4767bf","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-23T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amendment No. 1 to Delayed-Draw Bridge Credit Agreement","agreement_type":"credit_facility","counterparty":"Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A.","effective_date":"2026-03-18","item_codes_triggered":["1.01"],"value_text":"$500.0 million"},"claim":"Core Scientific, Inc./tx amended Amendment No. 1 to Delayed-Draw Bridge Credit Agreement with Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A. valued at $500.0 million (effective 2026-03-18).","evidence_excerpt":"On March 18, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement (the “Incremental Amendment”), by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A. (“JPM”), as amendment no. 1 term lender, which amends the Company’s existing credit agreement (the “Initial Credit Agreement”) with the lenders party thereto from time to time and the Agent to increase the term loan commitments thereunder by $500.0 million, to $1.0 billion total, pursuant to the accordion feature of the Initial Credit Agreement.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-020327","anchor_url":"https://secwatch.observer/filing/0001628280-26-020327#claim-d14b898b564449fae95773dafaddcef14e4767bf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026020327/0001628280-26-020327-index.htm"},{"fact_type":"debt_financing","fact_key":"be3b3469005fe663c3a7534464c2d6afdad825fd","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-06T23:59:59+00:00","payload":{"counterparty":"Morgan Stanley Senior Funding, Inc.","effective_date":"2026-03-04","event":"incurrence","instrument_type":"term_loan","interest_rate_text":"term SOFR (subject to a 0% floor), plus an applicable margin of 2.50% per annum","item_codes_triggered":["2.03"],"maturity_text":"the date that is 364 days after the Closing Date","principal_text":"$500.0 million"},"claim":"Core Scientific, Inc./tx incurred term loan of $500.0 million with Morgan Stanley Senior Funding, Inc. at term SOFR (subject to a 0% floor), plus an applicable margin of 2.50% per annum maturing the date that is 364 days after the Closing Date.","evidence_excerpt":"as administrative agent and collateral agent. The Credit Agreement provides for a senior secured loan facility (the “Term Loan Facility”) in an aggregate principal amount of $500.0 million. The Credit Agreement also provides for an accordion feature that allows the Company to request an increase in commitments under the Credit Agreement by up to an additional","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-015622","anchor_url":"https://secwatch.observer/filing/0001628280-26-015622#claim-be3b3469005fe663c3a7534464c2d6afdad825fd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026015622/0001628280-26-015622-index.htm"},{"fact_type":"material_agreement","fact_key":"311f0e8eaaa813e351dc50053103fec6eae6110d","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-06T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Credit Agreement","agreement_type":"credit_facility","counterparty":"Morgan Stanley Senior Funding, Inc.","effective_date":"2026-03-04","item_codes_triggered":["1.01"],"value_text":"$500.0 million"},"claim":"Core Scientific, Inc./tx entered into Credit Agreement with Morgan Stanley Senior Funding, Inc. valued at $500.0 million (effective 2026-03-04).","evidence_excerpt":"On March 4, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into a loan facility Credit Agreement (the “Credit Agreement”), by and among the Company, as borrower, the lenders party thereto from time to time (the “Lenders”) and Morgan Stanley Senior Funding, Inc. (“MSSF”), as administrative agent and collateral agent.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-26-015622","anchor_url":"https://secwatch.observer/filing/0001628280-26-015622#claim-311f0e8eaaa813e351dc50053103fec6eae6110d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026015622/0001628280-26-015622-index.htm"},{"fact_type":"auditor_change","fact_key":"b05ae1b2c226837594d897bd5799a5169ca6e416","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-02T23:59:59+00:00","payload":{"action":"non_reliance","auditor_name":"Marcum LLP","disagreement_text":"During the preparation of the consolidated financial statements for the year ended December 31, 2025, the Company determined that property, plant and equipment was overstated as a result of the improper continued capitalization of carrying values of assets committed to demolition in connection with the conversion of certain facilities from digital asset mining operations to high-performance computing (“HPC”) colocation infrastructure, which impacted the Company's previously issued consolidated financial statements for the year ended December 31, 2024, as well as the interim condensed consolidated financial statements for the Non-Reliance Periods.","effective_date":"2026-02-25","item_codes_triggered":["4.02"],"non_reliance_signal":"non_reliance","successor_auditor_name":null},"claim":"Core Scientific, Inc./tx reported that prior financial statements should not be relied upon.","evidence_excerpt":"On February 25, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of the Company, in consultation with management, determined that the Company’s consolidated financial statements for the three and six months ended June 30, 2024, the three and nine months ended September 30, 2024, the year ended December 31, 2024, the three months ended March 31, 2025, the three and six months ended June 30, 2025, and the three and nine months ended September 30, 2025 (the “Non-Reliance Periods”) should no longer be relied upon due to the accounting errors described below.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-013214","anchor_url":"https://secwatch.observer/filing/0001628280-26-013214#claim-b05ae1b2c226837594d897bd5799a5169ca6e416","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/0001628280-26-013214-index.htm"},{"fact_type":"material_agreement","fact_key":"a291e91268ace31db8f85264d5184b925b697db4","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-02-19T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Cooperation Agreement","agreement_type":"other","counterparty":"Two Seas Capital LP","effective_date":"2026-02-18","item_codes_triggered":["1.01"],"value_text":null},"claim":"Core Scientific, Inc./tx entered into Cooperation Agreement with Two Seas Capital LP (effective 2026-02-18).","evidence_excerpt":"On February 18, 2026, Core Scientific, Inc., a Delaware corporation (the “Company”) entered into a cooperation agreement (the “Cooperation Agreement”) with Two Seas Capital LP (“Two Seas”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-26-006133","anchor_url":"https://secwatch.observer/filing/0001140361-26-006133#claim-a291e91268ace31db8f85264d5184b925b697db4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000114036126006133/0001140361-26-006133-index.htm"},{"fact_type":"material_agreement","fact_key":"560ce708949a108d0e0ca42ca89e4255ae2f850e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-02-18T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Cooperation Agreement","agreement_type":"other","counterparty":"Two Seas Capital LP","effective_date":"2026-02-18","item_codes_triggered":["1.01"],"value_text":null},"claim":"Core Scientific, Inc./tx entered into Cooperation Agreement with Two Seas Capital LP (effective 2026-02-18).","evidence_excerpt":"On February 18, 2026, Core Scientific, Inc., a Delaware corporation (the “Company”), entered into a cooperation agreement (the “Cooperation Agreement”) with Two Seas Capital LP (“Two Seas”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-26-006037","anchor_url":"https://secwatch.observer/filing/0001140361-26-006037#claim-560ce708949a108d0e0ca42ca89e4255ae2f850e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000114036126006037/0001140361-26-006037-index.htm"},{"fact_type":"governance_change","fact_key":"8e51d12c3f816cdbd4f6b2176cca4e18c6b43773","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-05-27T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2025-05-27","item_codes_triggered":["5.03"],"summary_text":"Amended and restated bylaws to conform to charter amendments, revise procedural mechanics for stockholder nominations and proposals, and make ministerial changes."},"claim":"Core Scientific, Inc./tx: Amended and restated bylaws to conform to charter amendments, revise procedural mechanics for stockholder nominations and proposals, and make ministerial changes (effective 2025-05-27).","evidence_excerpt":"the Board approved, contingent and effective upon stockholder approval of the Approved Proposals and effectiveness of the Fourth Amended and Restated Certificate of Incorporation, the amendment and restatement of the Company’s Second Amended and Restated Bylaws","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-25-027960","anchor_url":"https://secwatch.observer/filing/0001628280-25-027960#claim-8e51d12c3f816cdbd4f6b2176cca4e18c6b43773","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025027960/0001628280-25-027960-index.htm"},{"fact_type":"governance_change","fact_key":"54d22adb255acb9f139a0f6c35cbcfd9131ae0f9","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-05-27T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-05-27","item_codes_triggered":["5.03"],"summary_text":"Eliminated classified board, removed supermajority vote requirement, and eliminated creditor consent rights upon emergence from bankruptcy, effective upon filing of Fourth Amended and Restated Certificate of Incorporation."},"claim":"Core Scientific, Inc./tx: Eliminated classified board, removed supermajority vote requirement, and eliminated creditor consent rights upon emergence from bankruptcy, effective upon filing of Fourth Amended and Restated Certificate of Incorporation (effective 2025-05-27).","evidence_excerpt":"the stockholder-approved amendments to the Certificate of Incorporation became effective upon the filing of the Fourth Amended and Restated Certificate of Incorporation on May 27, 2025 with the Secretary of State of Delaware.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-25-027960","anchor_url":"https://secwatch.observer/filing/0001628280-25-027960#claim-54d22adb255acb9f139a0f6c35cbcfd9131ae0f9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025027960/0001628280-25-027960-index.htm"},{"fact_type":"executive_change","fact_key":"c6b7b22772","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-05-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-05-14","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Elizabeth Crain was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"On May 14, 2025, the Board appointed Elizabeth Crain as a member of the Board and the Chair of the Audit Committee of the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-026294","anchor_url":"https://secwatch.observer/filing/0001628280-25-026294#claim-c6b7b22772","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025026294/0001628280-25-026294-index.htm"},{"fact_type":"executive_change","fact_key":"fbe29b6c74","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-05-16T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-05-13","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Todd Becker resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"On May 13, 2025, Todd Becker informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of his resignation as a member of the Board and the applicable committees thereof, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-026294","anchor_url":"https://secwatch.observer/filing/0001628280-25-026294#claim-fbe29b6c74","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025026294/0001628280-25-026294-index.htm"},{"fact_type":"auditor_change","fact_key":"c329db385baefa2f164120e029c6ef28ebe27dd7","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-03-13T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"KPMG LLP","disagreement_text":null,"effective_date":"2025-03-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Core Scientific, Inc./tx engaged KPMG LLP as its auditor.","evidence_excerpt":"approved the appointment of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the year ending December 31, 2025, effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-25-012594","anchor_url":"https://secwatch.observer/filing/0001628280-25-012594#claim-c329db385baefa2f164120e029c6ef28ebe27dd7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025012594/0001628280-25-012594-index.htm"},{"fact_type":"auditor_change","fact_key":"5a89a3d9646acf5165176b12a24ba3ba2c7ae47f","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-03-13T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Marcum LLP","disagreement_text":null,"effective_date":"2025-03-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"KPMG LLP"},"claim":"Core Scientific, Inc./tx dismissed Marcum LLP as its auditor.","evidence_excerpt":"Marcum LLP (“Marcum”), the Company’s prior independent registered public accounting firm, was informed on March 12, 2025 that it was dismissed as the Company’s independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-25-012594","anchor_url":"https://secwatch.observer/filing/0001628280-25-012594#claim-5a89a3d9646acf5165176b12a24ba3ba2c7ae47f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025012594/0001628280-25-012594-index.htm"},{"fact_type":"executive_change","fact_key":"1a6ee04667","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2025-03-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-03-17","interim":false,"role":"Executive Vice President, Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"James P. Nygaard, Jr. was appointed as Executive Vice President, Chief Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On March 2, 2025, the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) approved the appointment of James P. Nygaard, Jr., age 50, as the Company’s Executive Vice President, Chief Financial Officer, effective March 17, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-25-009570","anchor_url":"https://secwatch.observer/filing/0001628280-25-009570#claim-1a6ee04667","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828025009570/0001628280-25-009570-index.htm"},{"fact_type":"executive_change","fact_key":"c26f2b2f7b","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-09-06T23:59:59+00:00","payload":{"action":"resign","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Denise Sterling departed as Executive Vice President and Chief Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On September 5, 2024, Denise Sterling, Executive Vice President and Chief Financial Officer of the Company, informed the Company of her intention to resign from the Company pending the appointment of a successor.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-039711","anchor_url":"https://secwatch.observer/filing/0001628280-24-039711#claim-c26f2b2f7b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828024039711/0001628280-24-039711-index.htm"},{"fact_type":"earnings_release","fact_key":"963837f79f19f8aa6ffa88955415ecd8f2fa683a","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-03-12T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss of $195.7 million","period_text":"fourth fiscal quarter and full year ended December 31, 2023","report_date":"2024-03-12","result_type":"reported_results","revenue_text":"$141.9 million"},"claim":"Core Scientific, Inc./tx reported fourth fiscal quarter and full year ended December 31, 2023 results: revenue $141.9 million, net income Net loss of $195.7 million.","evidence_excerpt":"reported its financial results for the fiscal fourth quarter and year ended December 31, 2023. Fiscal Fourth Quarter 2023 Compared to Fiscal Fourth Year 2022 • Total revenue of $141.9 million, an increase of $20.7 million • Net loss of $195.7 million, an improvement of $239.2 million • Adjusted EBITDA of $57.5 million, an increase of $51.2 million Fiscal Year 2023","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-010544","anchor_url":"https://secwatch.observer/filing/0001628280-24-010544#claim-963837f79f19f8aa6ffa88955415ecd8f2fa683a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828024010544/0001628280-24-010544-index.htm"},{"fact_type":"governance_change","fact_key":"98342b2d0ec0b4e243794e1d698f9375a6c6a9d3","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2024-01-25","item_codes_triggered":["5.03"],"summary_text":"Company adopted Second Amended and Restated Bylaws on the Effective Date."},"claim":"Core Scientific, Inc./tx: Company adopted Second Amended and Restated Bylaws on the Effective Date (effective 2024-01-25).","evidence_excerpt":"On the Effective Date, in accordance with the Plan, the Company will file the Third Amended and Restated Certificate of Incorporation (the “ COI ”) with the Secretary of State of the State of Delaware and adopt the Second Amended and Restated Bylaws (the “ Bylaws ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-98342b2d0ec0b4e243794e1d698f9375a6c6a9d3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"governance_change","fact_key":"ad6dc799f3be72d72a127d2adc9270252f9b6191","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-01-25","item_codes_triggered":["5.03"],"summary_text":"Company filed Third Amended and Restated Certificate of Incorporation on the Effective Date."},"claim":"Core Scientific, Inc./tx: Company filed Third Amended and Restated Certificate of Incorporation on the Effective Date (effective 2024-01-25).","evidence_excerpt":"On the Effective Date, in accordance with the Plan, the Company will file the Third Amended and Restated Certificate of Incorporation (the “ COI ”) with the Secretary of State of the State of Delaware and adopt the Second Amended and Restated Bylaws (the “ Bylaws ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-ad6dc799f3be72d72a127d2adc9270252f9b6191","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"material_agreement","fact_key":"4bb6f733a67e097018a29e0bbac55a783a9d0218","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"New Miner Equipment Lender Agreements (Election 2)","agreement_type":"credit_facility","counterparty":"each Holder of an Allowed Miner Equipment Lender Secured Claim that is a Settling Miner Equipment Lender that elected on its Ballot to receive and is receiving the Miner Equipment Lender Treatment Election 2","effective_date":"2024-01-23","item_codes_triggered":["1.01"],"value_text":null},"claim":"Core Scientific, Inc./tx entered into New Miner Equipment Lender Agreements (Election 2) with each Holder of an Allowed Miner Equipment Lender Secured Claim that is a Settling Miner Equipment Lender that elected on its Ballot to receive and is receiving the Miner Equipment Lender Treatment Election 2 (effective 2024-01-23).","evidence_excerpt":"under the terms of the Plan, the Company entered into separate New Miner Equipment Lender Agreements (Election 2) with each Holder of an Allowed Miner Equipment Lender Secured Claim that is a Settling Miner Equipment Lender that elected on its Ballot (as defined in the RSA) to receive and is receiving the Miner Equipment Lender Treatment Election 2","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-4bb6f733a67e097018a29e0bbac55a783a9d0218","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"material_agreement","fact_key":"5149b831c1d732e5cd5dfee83de1b46fd5050ccc","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Exit Credit Agreement","agreement_type":"credit_facility","counterparty":"Wilmington Trust, National Association, as administrative agent and collateral agent, and the lenders party thereto","effective_date":"2024-01-23","item_codes_triggered":["1.01"],"value_text":"$80 million"},"claim":"Core Scientific, Inc./tx entered into Exit Credit Agreement with Wilmington Trust, National Association, as administrative agent and collateral agent, and the lenders party thereto valued at $80 million (effective 2024-01-23).","evidence_excerpt":"under the terms of the Plan, the Company entered into a credit and guaranty agreement, dated as of January 23, 2024 (the “ Exit Credit Agreement ”), by and among the Company, as borrower, the guarantors named therein, the lenders party thereto and Wilmington Trust, National Association, as administrative agent and collateral agent, consisting of an $80 million first-lien credit facility","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-5149b831c1d732e5cd5dfee83de1b46fd5050ccc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"9b0a51a037","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Eric Weiss was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-9b0a51a037","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"73045ca45f","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Yadin Rozov was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-73045ca45f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"815ccf511d","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jarrod Patten was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-815ccf511d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"902d17bae4","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jordan Levy was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-902d17bae4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"e7072908fe","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jeffrey Booth was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-e7072908fe","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"c30933f068","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Todd Becker was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-c30933f068","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"c81d712463","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Adam Sullivan was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss (collectively, the “ New Board Members ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-c81d712463","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"907a23c53b","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kneeland Youngblood resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-907a23c53b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"b9e2ac1aac","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Neal Goldman resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-b9e2ac1aac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"ef90571ad9","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Matthew Minnis resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-ef90571ad9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"579bf09bd6","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jarvis Hollingsworth resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-579bf09bd6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"14d4f6660b","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Darin Feinstein resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-14d4f6660b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"executive_change","fact_key":"63cef37d99","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael Levitt resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors (the “ Board ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-014941","anchor_url":"https://secwatch.observer/filing/0001193125-24-014941#claim-63cef37d99","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/0001193125-24-014941-index.htm"},{"fact_type":"governance_change","fact_key":"40a6319a1f23184b16f16f000aaa3a91b53a92a7","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Filing of Third Amended and Restated Certificate of Incorporation on the Effective Date"},"claim":"Core Scientific, Inc./tx: Filing of Third Amended and Restated Certificate of Incorporation on the Effective Date.","evidence_excerpt":"On the Effective Date, in accordance with the Plan, the Company will file the Third Amended and Restated Certificate of Incorporation (the “ COI ”) with the Secretary of State of the State of Delaware and adopt the Second Amended and Restated Bylaws (the “ Bylaws ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-40a6319a1f23184b16f16f000aaa3a91b53a92a7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"governance_change","fact_key":"e9db92db55fb7bd923d6836c46feea90fc931e88","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adoption of Second Amended and Restated Bylaws on the Effective Date"},"claim":"Core Scientific, Inc./tx: Adoption of Second Amended and Restated Bylaws on the Effective Date.","evidence_excerpt":"On the Effective Date, in accordance with the Plan, the Company will file the Third Amended and Restated Certificate of Incorporation (the “ COI ”) with the Secretary of State of the State of Delaware and adopt the Second Amended and Restated Bylaws (the “ Bylaws ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-e9db92db55fb7bd923d6836c46feea90fc931e88","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"material_agreement","fact_key":"0e68c025ef4cc78aba7f28acd1674eeafe3b7f0c","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Secured Convertible Notes Indenture","agreement_type":"notes_offering","counterparty":"guarantors party thereto and Wilmington Trust, National Association, as trustee and as collateral agent","effective_date":"2024-01-23","item_codes_triggered":["1.01"],"value_text":"$260.0 million aggregate principal amount of secured convertible notes due 2029"},"claim":"Core Scientific, Inc./tx entered into Secured Convertible Notes Indenture with guarantors party thereto and Wilmington Trust, National Association, as trustee and as collateral agent valued at $260.0 million aggregate principal amount of secured convertible notes due 2029 (effective 2024-01-23).","evidence_excerpt":"On the Effective Date, under the terms of the Plan, the Company issued $260.0 million aggregate principal amount of secured convertible notes due 2029 (the “ Secured Convertible Notes ”) pursuant to a secured convertible notes indenture (the “ Secured Convertible Notes Indenture ”) among (i) Core Scientific, Inc., as the issuer, (ii) the guarantors party thereto and (iii) Wilmington Trust, National Association, as trustee and as collateral agent for the Secured Convertible Notes","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-0e68c025ef4cc78aba7f28acd1674eeafe3b7f0c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"material_agreement","fact_key":"dbc1b879cc76e417134d9f7c4cff5328540ccf51","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"New Miner Equipment Lender Agreements (Election 2)","agreement_type":"credit_facility","counterparty":"Holders of Allowed Miner Equipment Lender Secured Claims that are Settling Miner Equipment Lenders electing Election 2","effective_date":"2024-01-23","item_codes_triggered":["1.01"],"value_text":"principal amount of eighty percent (80%) of each applicable Holders’ Allowed Miner Equipment Lender"},"claim":"Core Scientific, Inc./tx entered into New Miner Equipment Lender Agreements (Election 2) with Holders of Allowed Miner Equipment Lender Secured Claims that are Settling Miner Equipment Lenders electing Election 2 valued at principal amount of eighty percent (80%) of each applicable Holders’ Allowed Miner Equipment Lender (effective 2024-01-23).","evidence_excerpt":"On the Effective Date, under the terms of the Plan, the Company entered into separate New Miner Equipment Lender Agreements (Election 2) with each Holder of an Allowed Miner Equipment Lender Secured Claim that is a Settling Miner Equipment Lender that elected on its Ballot (as defined in the RSA) to receive and is receiving the Miner Equipment Lender Treatment Election 2","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-dbc1b879cc76e417134d9f7c4cff5328540ccf51","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"material_agreement","fact_key":"d0c849af6c5ceed84dec1e78b74ffe04cf3afb4e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Exit Credit Agreement","agreement_type":"credit_facility","counterparty":"lenders party thereto and Wilmington Trust, National Association, as administrative agent and collateral agent","effective_date":"2024-01-23","item_codes_triggered":["1.01"],"value_text":"$80 million first-lien credit facility"},"claim":"Core Scientific, Inc./tx entered into Exit Credit Agreement with lenders party thereto and Wilmington Trust, National Association, as administrative agent and collateral agent valued at $80 million first-lien credit facility (effective 2024-01-23).","evidence_excerpt":"On the Effective Date, under the terms of the Plan, the Company entered into a credit and guaranty agreement, dated as of January 23, 2024 (the “ Exit Credit Agreement ”), by and among the Company, as borrower, the guarantors named therein, the lenders party thereto and Wilmington Trust, National Association, as administrative agent and collateral agent, consisting of an $80 million first-lien credit facility","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-d0c849af6c5ceed84dec1e78b74ffe04cf3afb4e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"61964fdc48","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Eric Weiss was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-61964fdc48","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"63daece334","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Yadin Rozov was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-63daece334","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"8a801a42b1","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jarrod Patten was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-8a801a42b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"cac209f085","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jordan Levy was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-cac209f085","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"248f470d2e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jeffrey Booth was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-248f470d2e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"907701ea60","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Todd Becker was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-907701ea60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"9a587f2e6e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Adam Sullivan was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"As of the Effective Date, the Board consists of the following seven directors, who were appointed in accordance with the Plan: Adam Sullivan, Todd Becker, Jeffrey Booth, Jordan Levy, Jarrod Patten, Yadin Rozov and Eric Weiss","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-9a587f2e6e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"86e3427479","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kneeland Youngblood resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-86e3427479","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"85b1e831ff","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Neal Goldman resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-85b1e831ff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"e359c05a24","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Matthew Minnis resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-e359c05a24","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"8ea09be555","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jarvis Hollingsworth resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-8ea09be555","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"652a2997d5","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Darin Feinstein resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-652a2997d5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"executive_change","fact_key":"e1b942e315","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-01-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael Levitt resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Levitt, Darin Feinstein, Jarvis Hollingsworth, Matthew Minnis, Neal Goldman and Kneeland Youngblood resigned from the board of directors","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-24-013078","anchor_url":"https://secwatch.observer/filing/0001193125-24-013078#claim-e1b942e315","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524013078/0001193125-24-013078-index.htm"},{"fact_type":"distress_event","fact_key":"ccfdb4c2d39d4a8331df23a257218416b5ce0c54","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2024-01-17T23:59:59+00:00","payload":{"case_number":"22-90341 (CML)","court":"United States Bankruptcy Court for the Southern District of Texas","item_codes_triggered":["1.03"],"petition_date":"2022-12-21","proceeding_type":"chapter_11"},"claim":"Core Scientific, Inc./tx entered chapter 11 in United States Bankruptcy Court for the Southern District of Texas (petition 2022-12-21).","evidence_excerpt":"On December 21, 2022, Core Scientific, Inc. (the “ Company ”) and certain of its affiliates (collectively, the “ Debtors ”) filed voluntary petitions (the “ Chapter 11 Cases ”) in the United States Bankruptcy Court for the Southern District of Texas (the “ Bankruptcy Court ”) seeking relief under Chapter 11 of Title 11 of the United States Code (the “ Bankruptcy Code ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-008952","anchor_url":"https://secwatch.observer/filing/0001193125-24-008952#claim-ccfdb4c2d39d4a8331df23a257218416b5ce0c54","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312524008952/0001193125-24-008952-index.htm"},{"fact_type":"material_agreement","fact_key":"dc4d767463b0faef4a7a4c4ad20687a10480deb9","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-09-20T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase and Sale Agreement","agreement_type":"asset_purchase","counterparty":"Celsius Mining LLC","effective_date":"2023-09-14","item_codes_triggered":["1.01"],"value_text":"$45,000,000"},"claim":"Core Scientific, Inc./tx entered into Purchase and Sale Agreement with Celsius Mining LLC valued at $45,000,000 (effective 2023-09-14).","evidence_excerpt":"On September 14, 2023, the Debtors and Celsius entered into a settlement memorialized through a purchase and sale agreement (the “PSA”). The PSA provides that in exchange for a total purchase price of $45 million from Celsius, subject to certain conditions set forth in the PSA, the Debtors will (i) sell the Company’s Ward County, Texas bitcoin mining data center site (the “Cedarvale Facility”) and certain related assets to Celsius (collectively, the “Purchased Assets”), (ii) grant Celsius a perpetual, non-transferable (except as described in Section 14 of the PSA), non-exclusive limited license to use the Licensed Materials solely as and to the extent necessary to finish construction and development of the Cedarvale Facility, develop and construct mining facilities similar to the Improvements on other properties owned or leased by Celsius, and operate all of the foregoing, (iii) assume and assign certain executory contracts to Celsius and (iv) unequivocally, fully, irrevocably and fore","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-238132","anchor_url":"https://secwatch.observer/filing/0001193125-23-238132#claim-dc4d767463b0faef4a7a4c4ad20687a10480deb9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523238132/0001193125-23-238132-index.htm"},{"fact_type":"executive_change","fact_key":"717b0298d3","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-08-07T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-08-02","interim":true,"role":"interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Adam Sullivan was appointed as interim Chief Executive Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, the Board appointed Adam Sullivan to serve as interim CEO, effective as of August 2, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-204066","anchor_url":"https://secwatch.observer/filing/0001193125-23-204066#claim-717b0298d3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm"},{"fact_type":"executive_change","fact_key":"0db53bc5bb","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-08-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"routine","effective_date":"2023-08-02","interim":false,"role":"Co-Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Darin Feinstein resigned as Co-Chairman at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, Darin Feinstein informed the Board of his intention to resign from his position as Co-Chairman of the Board, effective as of August 2, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-204066","anchor_url":"https://secwatch.observer/filing/0001193125-23-204066#claim-0db53bc5bb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm"},{"fact_type":"executive_change","fact_key":"107c07bc8f","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-08-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"role_change","departure_tone":"routine","effective_date":"2023-08-02","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Adam Sullivan","successor_named":true},"claim":"Michael Levitt resigned as Chief Executive Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On August 2, 2023, Michael Levitt resigned from his role as Chief Executive Officer (“CEO”) of Core Scientific, Inc. (the “Company”), effective as of August 2, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-204066","anchor_url":"https://secwatch.observer/filing/0001193125-23-204066#claim-107c07bc8f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523204066/0001193125-23-204066-index.htm"},{"fact_type":"material_agreement","fact_key":"85bdc8d41680049195fa21943d9272eb085849ad","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-07-06T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"First Amendment to the Replacement DIP Credit Agreement","agreement_type":"credit_facility","counterparty":"B. Riley Commercial Capital, LLC, as administrative agent, and the Replacement DIP Lenders","effective_date":"2023-07-04","item_codes_triggered":["1.01"],"value_text":null},"claim":"Core Scientific, Inc./tx amended First Amendment to the Replacement DIP Credit Agreement with B. Riley Commercial Capital, LLC, as administrative agent, and the Replacement DIP Lenders (effective 2023-07-04).","evidence_excerpt":"On July 4, 2023, the Debtors, the Administrative Agent and the Replacement DIP Lenders entered into a First Amendment to the Replacement DIP Credit Agreement (the “First Amendment”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-182498","anchor_url":"https://secwatch.observer/filing/0001193125-23-182498#claim-85bdc8d41680049195fa21943d9272eb085849ad","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523182498/0001193125-23-182498-index.htm"},{"fact_type":"executive_change","fact_key":"f89f347dff","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-05-17T23:59:59+00:00","payload":{"action":"assumed additional role of Chief Administrative Officer","action_category":"role_change","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Legal Officer and Chief Administrative Officer","role_category":"general_counsel","successor_name":null,"successor_named":false},"claim":"Todd M. DuChene changed role as Chief Legal Officer and Chief Administrative Officer at Core Scientific, Inc./tx.","evidence_excerpt":"In connection with the appointment of Mr. Sullivan, Todd M. DuChene will continue to serve as the Company’s Chief Legal Officer while also assuming the new role of Chief Administrative Officer.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-147063","anchor_url":"https://secwatch.observer/filing/0001193125-23-147063#claim-f89f347dff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523147063/0001193125-23-147063-index.htm"},{"fact_type":"executive_change","fact_key":"3ea4e322bf","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-05-17T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-05-15","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Adam Sullivan was appointed as President at Core Scientific, Inc./tx.","evidence_excerpt":"On April 20, 2023, the Board of Directors (the “ Board ”) of Core Scientific, Inc. (the “ Company ”) appointed Adam Sullivan as President, effective May 15, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-147063","anchor_url":"https://secwatch.observer/filing/0001193125-23-147063#claim-3ea4e322bf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523147063/0001193125-23-147063-index.htm"},{"fact_type":"debt_financing","fact_key":"91fd69226a261dc0998ad27282a5d19794a464d3","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-03-02T23:59:59+00:00","payload":{"counterparty":"B. Riley Commercial Capital, LLC","effective_date":"2023-02-27","event":"incurrence","instrument_type":"credit_facility","interest_rate_text":"10% which will be payable in kind","item_codes_triggered":["2.03"],"maturity_text":"December 22, 2023","principal_text":"an aggregate principal amount not to exceed $70 million"},"claim":"Core Scientific, Inc./tx incurred credit facility of an aggregate principal amount not to exceed $70 million with B. Riley Commercial Capital, LLC at 10% which will be payable in kind maturing December 22, 2023.","evidence_excerpt":"The Replacement DIP Facility, among other things, provides for a non-amortizing super-priority senior secured term loan facility in an aggregate principal amount not to exceed $70 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-058334","anchor_url":"https://secwatch.observer/filing/0001193125-23-058334#claim-91fd69226a261dc0998ad27282a5d19794a464d3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523058334/0001193125-23-058334-index.htm"},{"fact_type":"material_agreement","fact_key":"53f9d396c7305385b71855edfdee1bb80f695f91","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-03-02T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Senior Secured Super-Priority Replacement Debtor-in-Possession Loan and Security Agreement","agreement_type":"credit_facility","counterparty":"B. Riley Commercial Capital, LLC","effective_date":"2023-02-27","item_codes_triggered":["1.01"],"value_text":"not to exceed $70 million"},"claim":"Core Scientific, Inc./tx entered into Senior Secured Super-Priority Replacement Debtor-in-Possession Loan and Security Agreement with B. Riley Commercial Capital, LLC valued at not to exceed $70 million (effective 2023-02-27).","evidence_excerpt":"On February 27, 2023, the Debtors entered into a Senior Secured Super-Priority Replacement Debtor-in-Possession Loan and Security Agreement governing the Replacement DIP Facility (the “Replacement DIP Credit Agreement”), with B. Riley Commercial Capital, LLC, as administrative agent (the “Administrative Agent”), and the lenders from time to time party thereto (collectively, the “Replacement DIP Lenders”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-058334","anchor_url":"https://secwatch.observer/filing/0001193125-23-058334#claim-53f9d396c7305385b71855edfdee1bb80f695f91","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523058334/0001193125-23-058334-index.htm"},{"fact_type":"material_agreement","fact_key":"fe14966369bc9622cf0966404786d993b7d1aa00","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-02-13T23:59:59+00:00","payload":{"action":"termination","agreement_name":"Restructuring Support Agreement","agreement_type":"other","counterparty":"Consenting Creditors","effective_date":"2023-02-09","item_codes_triggered":["1.02"],"value_text":"RSA terminated; Debtors no longer obligated to pursue Plan"},"claim":"Core Scientific, Inc./tx terminated Restructuring Support Agreement with Consenting Creditors valued at RSA terminated; Debtors no longer obligated to pursue Plan (effective 2023-02-09).","evidence_excerpt":"On February 9, 2023, the Debtors delivered written notice to the Consenting Creditors (the “RSA Termination Notice”) notifying such parties that the Debtors exercised their right to terminate the RSA, effective February 9, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-034521","anchor_url":"https://secwatch.observer/filing/0001193125-23-034521#claim-fe14966369bc9622cf0966404786d993b7d1aa00","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523034521/0001193125-23-034521-index.htm"},{"fact_type":"material_agreement","fact_key":"f52f6322cc569f2afe97ddd695f394a641cf039e","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-02-07T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Commitment Letter","agreement_type":"credit_facility","counterparty":"B. Riley Commercial Capital, LLC","effective_date":"2023-01-29","item_codes_triggered":["1.01"],"value_text":"aggregate principal amount not to exceed $70 million"},"claim":"Core Scientific, Inc./tx entered into Commitment Letter with B. Riley Commercial Capital, LLC valued at aggregate principal amount not to exceed $70 million (effective 2023-01-29).","evidence_excerpt":"Capitalized terms used but not defined herein have the meanings ascribed to them in that certain Commitment Letter (the “Commitment Letter”) dated as of January 29, 2023, by and between B. Riley Commercial Capital, LLC (the “Replacement DIP Lender”) and the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-027060","anchor_url":"https://secwatch.observer/filing/0001193125-23-027060#claim-f52f6322cc569f2afe97ddd695f394a641cf039e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523027060/0001193125-23-027060-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"df7cc4eb2196d6b57d8fcd3558ac9c7ff388d167","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2023-01-27T23:59:59+00:00","payload":{"company_response":"withdrew appeal","compliance_status":"delisting_pending","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":"2023-01-03","exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2022-12-22","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5101","5110(b)","IM-5101-1"],"rules_cited_in_text":true},"claim":"Core Scientific, Inc./tx received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).","evidence_excerpt":"December 22, 2022, Core Scientific, Inc. (the “Company”) received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of voluntary petitions filed by the Company and certain of its affiliates in the United States Bankruptcy Court for the Southern District of Texas seeking relief under Chapter 11 of Title 11 of the United States Code, and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. Following","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-016424","anchor_url":"https://secwatch.observer/filing/0001193125-23-016424#claim-df7cc4eb2196d6b57d8fcd3558ac9c7ff388d167","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312523016424/0001193125-23-016424-index.htm"},{"fact_type":"distress_event","fact_key":"dd043b3f6dc95f4b598e894973f8d1e525f54496","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-27T23:59:59+00:00","payload":{"case_number":null,"court":"United States Bankruptcy Court for the Southern District of Texas","item_codes_triggered":["1.03"],"petition_date":"2022-12-21","proceeding_type":"chapter_11"},"claim":"Core Scientific, Inc./tx entered chapter 11 in United States Bankruptcy Court for the Southern District of Texas (petition 2022-12-21).","evidence_excerpt":"on December 21, 2022, Core Scientific Inc. (the “Company”) and certain of its affiliates (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) in the United States Bankruptcy Court for the Southern District of Texas","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-312655","anchor_url":"https://secwatch.observer/filing/0001193125-22-312655#claim-dd043b3f6dc95f4b598e894973f8d1e525f54496","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522312655/0001193125-22-312655-index.htm"},{"fact_type":"debt_financing","fact_key":"8f562c8a80f1a51b99cdc99ffda6b8eca17d4a97","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-27T23:59:59+00:00","payload":{"counterparty":"Wilmington Savings Fund Society, FSB, as administrative agent, and the DIP Lenders","effective_date":"2022-12-22","event":"incurrence","instrument_type":"credit_facility","interest_rate_text":"10%","item_codes_triggered":["2.03"],"maturity_text":"June 21, 2023, which can be extended, under certain conditions, by an additional three months to September 21, 2023","principal_text":"up to $75 million"},"claim":"Core Scientific, Inc./tx incurred credit facility of up to $75 million with Wilmington Savings Fund Society, FSB, as administrative agent, and the DIP Lenders at 10% maturing June 21, 2023, which can be extended, under certain conditions, by an additional three months to September 21, 2023.","evidence_excerpt":"The DIP Lenders will provide new financing commitments to the Company under a new money multiple draw term loan facility (the “New Money DIP Facility”) in an initial aggregate principal amount of up to $75 million, approximately $57 million of which is currently committed to by the initial DIP Lenders, as may be increased from to time after the Closing Date to the extent additional commitments (in an aggregate principal amount not to exceed $75 million) are secured by further syndication. Under the New Money DIP Facility, (i) $37.5 million will be available following Bankruptcy Court approval on an interim basis (the “Interim DIP Order”), and (ii) up to $37.5 million will be available following Bankruptcy Court approval on a final basis (the “Final DIP Order”), subject to obtaining commitments for the full amount of the New Money DIP Facility. The DIP Credit Agreement provides for a credit facility pursuant to which up to $75 million of aggregate claims of the holders of the Convertibl","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-312655","anchor_url":"https://secwatch.observer/filing/0001193125-22-312655#claim-8f562c8a80f1a51b99cdc99ffda6b8eca17d4a97","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522312655/0001193125-22-312655-index.htm"},{"fact_type":"material_agreement","fact_key":"b4e23a533b3054dbec78fc4b4c7b0a77e0704dde","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Restructuring Support Agreement (RSA)","agreement_type":"notes_offering","counterparty":"certain holders of (x) Convertible Notes and/or (y) DIP Commitments or loans under the DIP Facility (the Consenting Creditors)","effective_date":"2022-12-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Core Scientific, Inc./tx entered into Restructuring Support Agreement (RSA) with certain holders of (x) Convertible Notes and/or (y) DIP Commitments or loans under the DIP Facility (the Consenting Creditors) (effective 2022-12-22).","evidence_excerpt":"On December 22, the Debtors entered into a Restructuring Support Agreement (together with all exhibits and schedules thereto, the “RSA”) with certain holders of (x) Convertible Notes and/or (y) DIP Commitments (as defined in the RSA) or loans under the DIP Facility (the “Consenting Creditors”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-312655","anchor_url":"https://secwatch.observer/filing/0001193125-22-312655#claim-b4e23a533b3054dbec78fc4b4c7b0a77e0704dde","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522312655/0001193125-22-312655-index.htm"},{"fact_type":"material_agreement","fact_key":"ce99997394b1a30f4c40a17952b364b6b16e9c8c","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-27T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Senior Secured Super-Priority Debtor-in-Possession Loan and Security Agreement (DIP Credit Agreement)","agreement_type":"credit_facility","counterparty":"Wilmington Savings Fund Society, FSB, as administrative agent, and the lenders from time to time party thereto","effective_date":"2022-12-22","item_codes_triggered":["1.01"],"value_text":"up to $75 million"},"claim":"Core Scientific, Inc./tx entered into Senior Secured Super-Priority Debtor-in-Possession Loan and Security Agreement (DIP Credit Agreement) with Wilmington Savings Fund Society, FSB, as administrative agent, and the lenders from time to time party thereto valued at up to $75 million (effective 2022-12-22).","evidence_excerpt":"the Debtors entered into a Senior Secured Super-Priority Debtor-in-Possession Loan and Security Agreement, dated as of December 22, 2022 (the “DIP Credit Agreement”), with Wilmington Savings Fund Society, FSB, as administrative agent (the “Administrative Agent”), and the lenders from time to time party thereto","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-312655","anchor_url":"https://secwatch.observer/filing/0001193125-22-312655#claim-ce99997394b1a30f4c40a17952b364b6b16e9c8c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522312655/0001193125-22-312655-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d970f61a283986c237bf4cff0fd9755c35d532bd","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-27T23:59:59+00:00","payload":{"company_response":"evaluating options","compliance_status":"delisting_pending","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":"2023-01-03","exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2022-12-22","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1","reported_value":null,"rule_numbers":["5101","5110(b)","IM-5101-1"],"rules_cited_in_text":true},"claim":"Core Scientific, Inc./tx received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).","evidence_excerpt":"December 22, 2022, the Company received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the staff of Nasdaq had determined that the Company’s common stock (the “Securities”) will be delisted from Nasdaq. Trading of the Securities will be suspended at the opening of business on January 3, 2023 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Securities from listi","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-312655","anchor_url":"https://secwatch.observer/filing/0001193125-22-312655#claim-d970f61a283986c237bf4cff0fd9755c35d532bd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522312655/0001193125-22-312655-index.htm"},{"fact_type":"distress_event","fact_key":"38e29b61ca2e691bedb015370ea9d3c03db19975","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"case_number":"22-90341","court":"United States Bankruptcy Court for the Southern District of Texas","item_codes_triggered":["1.03"],"petition_date":"2022-12-21","proceeding_type":"chapter_11"},"claim":"Core Scientific, Inc./tx entered chapter 11 in United States Bankruptcy Court for the Southern District of Texas (petition 2022-12-21).","evidence_excerpt":"On December 21, 2022, Core Scientific, Inc. (the “Company”) and certain of its affiliates (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) in the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) seeking relief under Chapter 11 of the United States Code (the “Bankruptcy Code”). The Company is seeking to have the Chapter 11 Cases jointly administered under Case No. 22-90341.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-38e29b61ca2e691bedb015370ea9d3c03db19975","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"debt_financing","fact_key":"0c213ce06da93b036551845019f3ea0b95dae03a","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"counterparty":"BRF Finance Co, LLC and B. Riley Commercial Capital, LLC","effective_date":"2022-12-15","event":"default","instrument_type":"loan","interest_rate_text":null,"item_codes_triggered":["2.04"],"maturity_text":null,"principal_text":"$41.8 million outstanding aggregate principal amount of loans"},"claim":"Core Scientific, Inc./tx reported a default on loan of $41.8 million outstanding aggregate principal amount of loans with BRF Finance Co, LLC and B. Riley Commercial Capital, LLC.","evidence_excerpt":"Bridge Promissory Notes, dated as of April 7, 2022 (as amended, restated, amended and restated, supplemented, or otherwise modified from time to time), by and between Core Scientific, Inc., as borrower, and BRF Finance Co, LLC and B. Riley Commercial Capital, LLC, as Noteholders, related to $41.8 million outstanding aggregate principal amount of loans.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-0c213ce06da93b036551845019f3ea0b95dae03a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"debt_financing","fact_key":"6c0a8e3a1ac45258ee42de28a13f13bad593f36c","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"counterparty":"BlockFi Lending LLC","effective_date":"2022-12-15","event":"default","instrument_type":"loan","interest_rate_text":null,"item_codes_triggered":["2.04"],"maturity_text":null,"principal_text":"$47.2 million outstanding aggregate principal amount of loans"},"claim":"Core Scientific, Inc./tx reported a default on loan of $47.2 million outstanding aggregate principal amount of loans with BlockFi Lending LLC.","evidence_excerpt":"Facility and Security Agreement, dated as of December 30, 2021, by and between Core Scientific Operating Company (f/k/a Core Scientific, Inc.), as borrower, and BlockFi Lending LLC, as lender, related to $47.2 million outstanding aggregate principal amount of loans.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-6c0a8e3a1ac45258ee42de28a13f13bad593f36c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"debt_financing","fact_key":"f8458bc0fabfda522bff5681320ac0b9ef4fd36b","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"counterparty":"Barings Private Credit Corp., Barings Capital Investment Corporation and Barings BDC, Inc.","effective_date":"2022-12-15","event":"default","instrument_type":"loan","interest_rate_text":null,"item_codes_triggered":["2.04"],"maturity_text":null,"principal_text":"$63.8 million aggregate principal amount remain outstanding"},"claim":"Core Scientific, Inc./tx reported a default on loan of $63.8 million aggregate principal amount remain outstanding with Barings Private Credit Corp., Barings Capital Investment Corporation and Barings BDC, Inc..","evidence_excerpt":"Master Security Agreement, dated as of March 24, 2022, by and between the Company, as borrower, and Barings Private Credit Corp., Barings Capital Investment Corporation and Barings BDC, Inc. as lenders, of which $63.8 million aggregate principal amount remain outstanding.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-f8458bc0fabfda522bff5681320ac0b9ef4fd36b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"debt_financing","fact_key":"f3fd56545d08b375a55e1fdeb7edcb6336f1d3be","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"counterparty":"U.S. Bank National Association","effective_date":"2022-12-15","event":"default","instrument_type":"convertible_notes","interest_rate_text":"10.00%","item_codes_triggered":["2.04"],"maturity_text":"April 19, 2025","principal_text":"$215 million aggregate principal amount remain outstanding"},"claim":"Core Scientific, Inc./tx reported a default on convertible notes of $215 million aggregate principal amount remain outstanding with U.S. Bank National Association at 10.00% maturing April 19, 2025.","evidence_excerpt":"Secured Convertible Note Purchase Agreement, dated as of April 19, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among Core Scientific Holding Co., the guarantors, U.S. Bank National Association, as note agent and collateral agent, and the purchasers of the notes issued thereunder, governing the 10.00% Convertible Notes due 2025 which mature on April 19, 2025, of which $215 million aggregate principal amount remain outstanding, excluding accrued PIK interest.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-f3fd56545d08b375a55e1fdeb7edcb6336f1d3be","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"debt_financing","fact_key":"7f50a4855d0b18528e5407dd1991944696f2b768","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-21T23:59:59+00:00","payload":{"counterparty":"U.S. Bank National Association","effective_date":"2022-12-15","event":"default","instrument_type":"convertible_notes","interest_rate_text":"10.00%","item_codes_triggered":["2.04"],"maturity_text":"April 19, 2025","principal_text":"$298.3 million aggregate principal amount remain outstanding"},"claim":"Core Scientific, Inc./tx reported a default on convertible notes of $298.3 million aggregate principal amount remain outstanding with U.S. Bank National Association at 10.00% maturing April 19, 2025.","evidence_excerpt":"Convertible Note Purchase Agreement, dated as of August 20, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among Core Scientific Holding Co., the guarantors, U.S. Bank National Association, as note agent and collateral agent, and the purchasers of the notes issued thereunder, governing the 10.00% Convertible Notes due 2025 which mature on April 19, 2025, of which $298.3 million aggregate principal amount remain outstanding, excluding accrued PIK interest.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-22-310173","anchor_url":"https://secwatch.observer/filing/0001193125-22-310173#claim-7f50a4855d0b18528e5407dd1991944696f2b768","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522310173/0001193125-22-310173-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ab82aa873d94bf974be969232be11f00176573ba","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-12-16T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2022-12-13","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5450(a)(1)"],"rules_cited_in_text":true},"claim":"Core Scientific, Inc./tx received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"December 13, 2022, Core Scientific, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued inclusion on The Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). This Notice has no immed","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-307393","anchor_url":"https://secwatch.observer/filing/0001193125-22-307393#claim-ab82aa873d94bf974be969232be11f00176573ba","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522307393/0001193125-22-307393-index.htm"},{"fact_type":"executive_change","fact_key":"cf173109f2","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-11-28T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-11-21","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Stacie Olivares resigned as Director at Core Scientific, Inc./tx.","evidence_excerpt":"On November 21, 2022, Stacie Olivares informed the Board of Directors (the “Board”) of Core Scientific, Inc. (the “Company”) of her intention to resign as a director of the Board and any committees thereof effective November 21, 2022.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001628280-22-030867","anchor_url":"https://secwatch.observer/filing/0001628280-22-030867#claim-cf173109f2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022030867/0001628280-22-030867-index.htm"},{"fact_type":"auditor_change","fact_key":"848d969fb34eef7cadd6ccefae73d118a00f9043","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-11-23T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Marcum LLP","disagreement_text":null,"effective_date":"2022-11-22","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Core Scientific, Inc./tx engaged Marcum LLP as its auditor.","evidence_excerpt":"on October 24, 2022, the Audit Committee of the Company’s Board of Directors approved the engagement of Marcum LLP (\"Marcum\") as its independent registered public accounting firm for the fiscal year ending December 31, 2022, subject to Marcum’s completion of their client acceptance procedures.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-22-030748","anchor_url":"https://secwatch.observer/filing/0001628280-22-030748#claim-848d969fb34eef7cadd6ccefae73d118a00f9043","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022030748/0001628280-22-030748-index.htm"},{"fact_type":"auditor_change","fact_key":"2b3da64ef7770a07a00e558a1bcf484e2ab4aa9c","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-11-23T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Ernst & Young LLP","disagreement_text":null,"effective_date":"2022-09-30","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Marcum LLP"},"claim":"Core Scientific, Inc./tx dismissed Ernst & Young LLP as its auditor.","evidence_excerpt":"At the same meeting, the Audit Committee approved the dismissal of Ernst & Young LLP (\"EY\") as independent registered public accounting firm of the Company effective upon the date of the filing of the quarterly report on Form 10-Q for the quarter ending September 30, 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-22-030748","anchor_url":"https://secwatch.observer/filing/0001628280-22-030748#claim-2b3da64ef7770a07a00e558a1bcf484e2ab4aa9c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022030748/0001628280-22-030748-index.htm"},{"fact_type":"executive_change","fact_key":"48632a8f05","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-11-15T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-11-14","interim":false,"role":"President and Chief Legal Officer","role_category":"president","successor_name":null,"successor_named":false},"claim":"Todd DuChene was appointed as President and Chief Legal Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On November 9, 2022, the board of directors of Core Scientific, Inc. (the “Company”) appointed Todd DuChene to serve as the Company’s President and Chief Legal Officer, effective November 14, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-285502","anchor_url":"https://secwatch.observer/filing/0001193125-22-285502#claim-48632a8f05","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522285502/0001193125-22-285502-index.htm"},{"fact_type":"auditor_change","fact_key":"fd2a119b323c42886d570c1a7198c63abfb1a05f","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-10-28T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Marcum LLP","disagreement_text":null,"effective_date":"2022-10-24","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Core Scientific, Inc./tx engaged Marcum LLP as its auditor.","evidence_excerpt":"At a meeting held on October 24, 2022, the Audit Committee of the Board of Directors of Core Scientific, Inc. (the “Company”) approved the engagement of Marcum LLP (“Marcum”) as its independent registered public accounting firm for the fiscal year ending December 31, 2022, subject to Marcum’s completion of their client acceptance procedures.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-22-027303","anchor_url":"https://secwatch.observer/filing/0001628280-22-027303#claim-fd2a119b323c42886d570c1a7198c63abfb1a05f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022027303/0001628280-22-027303-index.htm"},{"fact_type":"auditor_change","fact_key":"719c75813c57db53d6d33779e2313ddd577c419a","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-10-28T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Ernst & Young LLP","disagreement_text":null,"effective_date":"2022-09-30","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Marcum LLP"},"claim":"Core Scientific, Inc./tx dismissed Ernst & Young LLP as its auditor.","evidence_excerpt":"At the same meeting, the Audit Committee approved the dismissal of Ernst & Young LLP (\"EY\") as independent registered public accounting firm of the Company effective upon the date of the filing of the quarterly report on Form 10-Q for the quarter ending September 30, 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-22-027303","anchor_url":"https://secwatch.observer/filing/0001628280-22-027303#claim-719c75813c57db53d6d33779e2313ddd577c419a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022027303/0001628280-22-027303-index.htm"},{"fact_type":"executive_change","fact_key":"d64f49fc30","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-10-27T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-10-26","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Neal P. Goldman was appointed as Director at Core Scientific, Inc./tx.","evidence_excerpt":"On October 26, 2022, Core Scientific, Inc. (“Core Scientific,” “we,” “our,” “us” or the “Company”) announced the appointment of Neal P. Goldman to its board of directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-270236","anchor_url":"https://secwatch.observer/filing/0001193125-22-270236#claim-d64f49fc30","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522270236/0001193125-22-270236-index.htm"},{"fact_type":"executive_change","fact_key":"9a6a6fd607","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-10-25T23:59:59+00:00","payload":{"action":"will serve as","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2022-10-19","interim":false,"role":"principal accounting officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Denise Sterling changed role as principal accounting officer at Core Scientific, Inc./tx.","evidence_excerpt":"Denise Sterling, the Company’s Executive Vice President and Chief Financial Officer, will serve as principal accounting officer, effective immediately, in addition to her existing responsibilities.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-22-026982","anchor_url":"https://secwatch.observer/filing/0001628280-22-026982#claim-9a6a6fd607","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022026982/0001628280-22-026982-index.htm"},{"fact_type":"executive_change","fact_key":"762f83e145","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-10-25T23:59:59+00:00","payload":{"action":"eliminated","action_category":"departure","departure_tone":"routine","effective_date":"2022-10-19","interim":false,"role":"Controller and Chief Accounting Officer","role_category":"other_named_officer","successor_name":"Denise Sterling","successor_named":true},"claim":"Brian Neville departed as Controller and Chief Accounting Officer at Core Scientific, Inc./tx.","evidence_excerpt":"On October 19, 2022, the Company eliminated the position held by Brian Neville, the Company’s Controller and Chief Accounting Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-22-026982","anchor_url":"https://secwatch.observer/filing/0001628280-22-026982#claim-762f83e145","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828022026982/0001628280-22-026982-index.htm"},{"fact_type":"executive_change","fact_key":"02efdc7346","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-04-20T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-05","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Denise Sterling was appointed as Chief Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"Denise Sterling, the former Senior Vice President of Finance of the Company, assumed the role of Chief Financial Officer on April 5, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-111309","anchor_url":"https://secwatch.observer/filing/0001193125-22-111309#claim-02efdc7346","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522111309/0001193125-22-111309-index.htm"},{"fact_type":"executive_change","fact_key":"9bee788b0d","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-04-20T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-04-04","interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":"Denise Sterling","successor_named":true},"claim":"Michael Trzupek resigned as Executive Vice President and Chief Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"Michael Trzupek, Executive Vice President and Chief Financial Officer of the Company, notified the Board of Directors of the Company of his decision to resign from his position on April 4, 2022, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-111309","anchor_url":"https://secwatch.observer/filing/0001193125-22-111309#claim-9bee788b0d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522111309/0001193125-22-111309-index.htm"},{"fact_type":"executive_change","fact_key":"ef704cad01","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-04-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-04-04","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Denise Sterling was appointed as Chief Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"the Board of Directors (the “Board”) of the Company approved the appointment of Denise Sterling, age 57, as the Company’s Chief Financial Officer, effective April 4, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-095692","anchor_url":"https://secwatch.observer/filing/0001193125-22-095692#claim-ef704cad01","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522095692/0001193125-22-095692-index.htm"},{"fact_type":"executive_change","fact_key":"9aaa8a2826","cik":1839341,"ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2022-04-05T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-04-04","interim":false,"role":"Executive Vice President, Chief Financial Officer and Principal Financial Officer","role_category":"cfo","successor_name":"Denise Sterling","successor_named":true},"claim":"Michael Trzupek resigned as Executive Vice President, Chief Financial Officer and Principal Financial Officer at Core Scientific, Inc./tx.","evidence_excerpt":"Mr. Trzupek's resignation was a personal decision to pursue other business opportunities in the Pacific Northwest and not due to any disagreement with the Company’s management team, operations, financials, policies or procedures.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-095692","anchor_url":"https://secwatch.observer/filing/0001193125-22-095692#claim-9aaa8a2826","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1839341/000119312522095692/0001193125-22-095692-index.htm"}]}